PAK1 Kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Rettig, Matthew ^a,b,c   Trinidad, Kenny ^a   Pezeshkpour, G ^d   Frost, Patrick ^a   Sharma, Sherven ^b,e   Moatamed, Farhad ^d   Tamanoi, Fuyuhiko ^b,c   Mortazavi, Fariborz ^a,b,c  

^a Division of Hematology Oncology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Pathology West Los Angeles VA ^*  (United States)

^e Institute of Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CATENIN; CRK II SERINE 41; P21 ACTIVATED KINASE 1; PROTEIN P120; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CELL INVASION; CELL MOTILITY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; WOUND HEALING;

CARCINOMA, NON-SMALL-CELL LUNG; CATENINS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; P21-ACTIVATED KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-CRK; SERINE;

EID: 84864405697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042012     Document Type: Article

References (49)

1. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, et al. ((2002)) High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. JClinOncol 20:: 2417--2428.
2. Chung Y, Lam AK, Luk JM, Law S, Chan KW, et al. ((2007)) Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. AnnSurgOncol 14:: 3260--3267.
3. Davis MA, Ireton RC, Reynolds AB, ((2003)) A core function for p120-catenin in cadherin turnover. JCell Biol 163:: 525--534.
4. Ireton RC, Davis MA, van HJ, Mariner DJ, Barnes K, et al. ((2002)) A novel role for p120 catenin in E-cadherin function. JCell Biol 159:: 465--476.
5. Kelly KF, Spring CM, Otchere AA, Daniel JM, ((2004)) NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. JCell Sci 117:: 2675--2686.
6. Reynolds AB, Carnahan RH, ((2004)) Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer. SeminCell DevBiol 15:: 657--663.
7. Reynolds AB, ((2007)) p120-catenin: Past and present. BiochimBiophysActa 1773:: 2--7.
8. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, et al. ((2003)) Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. JCell Biol 163:: 535--545.
9. Xiao K, Oas RG, Chiasson CM, Kowalczyk AP, ((2007)) Role of p120-catenin in cadherin trafficking. BiochimBiophysActa 1773:: 8--16.
10. Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, et al. ((2008)) Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters. World JGastroenterol 14:: 3739--3744.
11. Mortazavi F, An J, Dubinett S, Rettig M, ((2010)) p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells. MolCancer Res 8:: 762--774.
12. Mortazavi F, Dubinett S, Rettig M, ((2011)) c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells. ClinExpMetastasis 28:: 391--404.
13. Feller SM, ((2001)) Crk family adaptors-signalling complex formation and biological roles. Oncogene 20:: 6348--6371.
14. Birge RB, Kalodimos C, Inagaki F, Tanaka S, ((2009)) Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell CommunSignal 7:: 13.
15. Mayer BJ, Hanafusa H, ((1990)) Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. ProcNatlAcadSciUSA 87:: 2638--2642.
16. Kain KH, Gooch S, Klemke RL, ((2003)) Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion. Oncogene 22:: 6071--6080.
17. Cho SY, Klemke RL, ((2000)) Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. JCell Biol 149:: 223--236.
18. Zandy NL, Playford M, Pendergast AM, ((2007)) Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. ProcNatlAcadSciUSA 104:: 17686--17691.
19. Zandy NL, Pendergast AM, ((2008)) Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases. Cell Cycle 7:: 444--448.
20. Oehrl W, Kardinal C, Ruf S, Adermann K, Groffen J, et al. ((1998)) The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins. Oncogene 17:: 1893--1901.
21. Shi CS, Tuscano J, Kehrl JH, ((2000)) Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation. Blood 95:: 776--782.
22. Dummler B, Ohshiro K, Kumar R, Field J, ((2009)) Pak protein kinases and their role in cancer. Cancer Metastasis Rev 28:: 51--63.
23. Stofega MR, Sanders LC, Gardiner EM, Bokoch GM, ((2004)) Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions. MolBiolCell 15:: 2965--2977.
24. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, et al. ((2000)) Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. JBiolChem 275:: 36238--36244.
25. Ong CC, Jubb AM, Haverty PM, Zhou W, Tran V, et al. ((2011)) Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. ProcNatlAcadSciUSA 108:: 7177--7182.
26. Escalante M, Courtney J, Chin WG, Teng KK, Kim JI, et al. ((2000)) Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis. JBiolChem 275:: 24787--24797.
27. Hempstead BL, Birge RB, Fajardo JE, Glassman R, Mahadeo D, et al. ((1994)) Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. MolCell Biol 14:: 1964--1971.
28. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, et al. ((2003)) Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 22:: 7950--7957.
29. Lightcap CM, Sun S, Lear JD, Rodeck U, Polenova T, et al. ((2008)) Biochemical and structural characterization of the Pak1-LC8 interaction. JBiolChem 283:: 27314--27324.
30. Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA, ((1995)) Identification of a mouse p21Cdc42/Rac activated kinase. JBiolChem 270:: 22731--22737.
31. Kiosses WB, Daniels RH, Otey C, Bokoch GM, Schwartz MA, ((1999)) A role for p21-activated kinase in endothelial cell migration. JCell Biol 147:: 831--844.
32. Sells MA, Boyd JT, Chernoff J, ((1999)) p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. JCell Biol 145:: 837--849.
33. rias-Romero LE, Chernoff J, ((2008)) A tale of two Paks. BiolCell 100:: 97--108.
34. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, et al. ((2003)) Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. AmJPathol 163:: 985--992.
35. Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, et al. ((2004)) Pak-1 expression increases with progression of colorectal carcinomas to metastasis. ClinCancer Res 10:: 3448--3456.
36. Zegers MM, Forget MA, Chernoff J, Mostov KE, Ter Beest MB, et al. ((2003)) Pak1 and PIX regulate contact inhibition during epithelial wound healing. EMBO J 22:: 4155--4165.
37. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, et al. ((2002)) Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. NatCell Biol 4:: 681--690.
38. Edwards DC, Sanders LC, Bokoch GM, Gill GN, ((1999)) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. NatCell Biol 1:: 253--259.
39. King AJ, Sun H, Diaz B, Barnard D, Miao W, et al. ((1998)) The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396:: 180--183.
40. Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, et al. ((1997)) Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 16:: 6426--6438.
41. Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH, ((1996)) Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. MolCell Biol 16:: 3707--3713.
42. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, et al. ((1995)) Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. JBiolChem 270:: 23934--23936.
43. Brown JL, Stowers L, Baer M, Trejo J, Coughlin S, et al. ((1996)) Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. CurrBiol 6:: 598--605.
44. Teramoto H, Crespo P, Coso OA, Igishi T, Xu N, et al. ((1996)) The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. JBiolChem 271:: 25731--25734.
45. Westwick JK, Lambert QT, Clark GJ, Symons M, Van AL, et al. ((1997)) Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. MolCell Biol 17:: 1324--1335.
46. Gajewski TF, Thompson CB, ((1996)) Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87:: 589--592.
47. Sastry KS, Smith AJ, Karpova Y, Datta SR, Kulik G, ((2006)) Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. JBiolChem 281:: 20891--20901.
48. Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, et al. ((2000)) p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. MolCell Biol 20:: 453--461.
49. Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL, ((2006)) HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Res 66:: 9591--9600.